A systematic review of the direct economic burden of type 2 diabetes in china.
A systematic review of the direct economic burden of type 2 diabetes in china.
复制标题
DOI：
10.1007/s13300-015-0096-0
复制
发表时间：
2015-03
期刊：
影响因子：
3.8
通讯作者：
Dong, Hengjin
中科院分区：
文献类型：
--
作者：
Hu, Huimei;Sawhney, Monika;Shi, Lizheng;Duan, Shengnan;Yu, Yunxian;Wu, Zhihong;Qiu, Guixing;Dong, Hengjin
2型糖尿病与急性和慢性并发症相关，并对患者及其家庭以及社会造成巨大的经济、社会和医疗负担。本研究旨在评估中国2型糖尿病的直接经济负担。数据来源：使用Pubmed、EBSCO、Elsevier ScienceDirect、Web of Science等数据库和一系列中文数据库（包括万方数据、中国知网（CNKI）和中国科技期刊数据库），对截至2014年与2型糖尿病相关的疾病成本、医疗保健成本、直接服务成本、药物成本和卫生支出进行了系统性综述。影响住院和药品费用的因素也被确定。研究合格性标准：（1）估计我国2型糖尿病患者的直接经济负担，包括住院和门诊费用;（2）评价影响直接经济负担的因素。排除仅关注糖尿病药物成本-效果分析的文章。在中国，2型糖尿病的直接经济负担随着时间的推移而增加，2008年，直接医疗费用达到91亿美元，门诊和住院费用都有所增加。收入水平、医疗保险类型、医院护理水平、并发症类型和数量是影响糖尿病相关住院费用的主要因素。与城市地区相比，农村地区2型糖尿病的直接非医疗费用明显更大。2型糖尿病的直接经济负担对中国构成了重大挑战。为了解决与2型糖尿病相关的经济负担，需要采取措施降低糖尿病的患病率和严重程度以及住院费用。
Type 2 diabetes is associated with acute and chronic complications and poses a large economic, social, and medical burden on patients and their families as well as society. This study aims to evaluate the direct economic burden of type 2 diabetes in China. Data source: systematic review on cost of illness, health care costs, direct service costs, drug costs, and health expenditures in relation to type 2 diabetes was conducted up to 2014 using databases such as Pubmed; EBSCO; Elsevier ScienceDirect, Web of Science; and a series of Chinese databases, including Wanfang Data, China National Knowledge Infrastructure (CNKI), and the China Science and Technology Journal Database. Factors influencing hospitalization and drug fees were also identified. Study eligibility criteria: (1) estimation of the direct economic burden including hospitalization and outpatient cost of type 2 diabetes patients in China; (2) evaluation of the factors influencing the direct economic burden. Articles only focusing on the cost-effectiveness analysis of diabetes drugs were excluded. The direct economic burden of type 2 diabetes has increased over time in China, and in 2008, the direct medical cost reached $9.1 billion, Both outpatient and inpatient costs have increased. Income level, type of medical insurance, the level of hospital care, and type and number of complications are primary factors influencing diabetes related hospitalization costs. Compared to urban areas, the direct non-medical cost of type 2 diabetes in rural areas is significantly greater. The direct economic burden of type 2 diabetes poses a significant challenge to China. To address the economic burden associated with type 2 diabetes, measures need to be taken to reduce prevalence rate and severity of diabetes and hospitalization cost.
登录
查看更多内容
影响因子：
16.2
作者：
OLSSON, J;PERSSON, U;MELANDER, A
通讯作者：
MELANDER, A
影响因子：
16.2
作者：
Gu, K;Cowie, CC;Harris, MI
通讯作者：
Harris, MI
影响因子：
16.2
作者：
Roglic, G;Unwin, N;King, H
通讯作者：
King, H
影响因子：
16.2
作者：
Pan, XR;Yang, WY;Liu, J
通讯作者：
Liu, J
从2002年到2030年，全球死亡率和疾病负担的预测。
影响因子：
15.8
作者：
Mathers, Colin D.;Loncar, Dejan
通讯作者：
Loncar, Dejan